Coherus BioSciences, Inc is a biopharmaceutical company based in Redwood City, CA, dedicated to delivering innovative medicines that have a positive impact on individuals with life-altering diseases. With a focus on immuno-oncology, Coherus is committed to advancing a diverse portfolio of next-generation therapies to transform cancer treatment and improve survival rates for patients with challenging tumors.
Coherus BioSciences is known for its groundbreaking FDA-approved therapy, LOQTORZI, which is the first and only treatment for recurrent or metastatic nasopharyngeal carcinoma (NPC) available in the United States. Additionally, the company's pipeline includes several clinical stage immuno-oncology drug candidates that target the tumor microenvironment, aiming to enhance patient outcomes and revolutionize cancer care.
Generated from the website